Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Avorn

Showing results (91-100 of 184) with videos related to

Pageof 19
Sort By:
Blood|August 29, 2000
Immune tolerance induction in hemophilia patients with inhibitors: costly can be cheaperA B Colowick, R L Bohn, J Avorn, et al.
Journal of General Internal Medicine|June 1, 1995
A cost-effectiveness model of thrombolytic therapy for acute myocardial infarctionS C Kalish, J H Gurwitz, H M Krumholz, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 8, 2002
Porcine factor VIII: pharmacoeconomics of inhibitor therapyB M Ewenstein, J Avorn, K G Putnam, et al.
Archives of Internal Medicine|May 1, 1987
Overmedication of the low-weight elderlyE W Campion, J Avorn, V A Reder, et al.
Journal of the American Geriatrics Society|August 1, 1991
Resident behavior and staff distress in the nursing homeD E Everitt, D R Fields, S S Soumerai, et al.
Infection Control and Hospital Epidemiology|November 1, 1990
Changing surgical antimicrobial prophylaxis practices through education targeted at senior department leadersD E Everitt, S B Soumerai, J Avorn, et al.
Journal of General Internal Medicine|January 1, 1997
How do older persons define constipation? Implications for therapeutic managementD Harari, J H Gurwitz, J Avorn, et al.
Reviews of Infectious Diseases|July 1, 1989
Effect of hospitalwide change in clindamycin dosing schedule on clinical outcomeD Buchwald, S B Soumerai, N VanDevanter, et al.
Annals of Internal Medicine|June 1, 1992
Aging and the anticoagulant response to warfarin therapyJ H Gurwitz, J Avorn, D Ross-Degnan, et al.
Journal of Clinical Epidemiology|August 28, 1999
Aging, comorbidity, and reduced rates of drug treatment for diabetes mellitusR J Glynn, M Monane, J H Gurwitz, et al.
Pageof 19

Showing results (91-100 of 184) with videos related to

Sort By:
Pageof 19
Blood|August 29, 2000
Immune tolerance induction in hemophilia patients with inhibitors: costly can be cheaperA B Colowick, R L Bohn, J Avorn, et al.
Journal of General Internal Medicine|June 1, 1995
A cost-effectiveness model of thrombolytic therapy for acute myocardial infarctionS C Kalish, J H Gurwitz, H M Krumholz, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 8, 2002
Porcine factor VIII: pharmacoeconomics of inhibitor therapyB M Ewenstein, J Avorn, K G Putnam, et al.
Archives of Internal Medicine|May 1, 1987
Overmedication of the low-weight elderlyE W Campion, J Avorn, V A Reder, et al.
Journal of the American Geriatrics Society|August 1, 1991
Resident behavior and staff distress in the nursing homeD E Everitt, D R Fields, S S Soumerai, et al.
Infection Control and Hospital Epidemiology|November 1, 1990
Changing surgical antimicrobial prophylaxis practices through education targeted at senior department leadersD E Everitt, S B Soumerai, J Avorn, et al.
Journal of General Internal Medicine|January 1, 1997
How do older persons define constipation? Implications for therapeutic managementD Harari, J H Gurwitz, J Avorn, et al.
Reviews of Infectious Diseases|July 1, 1989
Effect of hospitalwide change in clindamycin dosing schedule on clinical outcomeD Buchwald, S B Soumerai, N VanDevanter, et al.
Annals of Internal Medicine|June 1, 1992
Aging and the anticoagulant response to warfarin therapyJ H Gurwitz, J Avorn, D Ross-Degnan, et al.
Journal of Clinical Epidemiology|August 28, 1999
Aging, comorbidity, and reduced rates of drug treatment for diabetes mellitusR J Glynn, M Monane, J H Gurwitz, et al.
Pageof 19